214 related articles for article (PubMed ID: 37864589)
21. [Adiponectin Receptor Agonist AdipoRon Inhibits the Proliferation of Myeloma Cells via the AMPK/Autophagy Pathway].
Wang SJ; Wang C; Wang WQ; Hao QQ; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):171-176. PubMed ID: 32027272
[TBL] [Abstract][Full Text] [Related]
22. AdipoRon: A Novel Insulin Sensitizer in Various Complications and the Underlying Mechanisms: A Review.
Bhat IA; Kabeer SW; Reza MI; Mir RH; Dar MO
Curr Mol Pharmacol; 2020; 13(2):94-107. PubMed ID: 31642417
[TBL] [Abstract][Full Text] [Related]
23. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice.
Wang Y; Wan Y; Ye G; Wang P; Xue X; Wu G; Ye B
Eur J Pharm Sci; 2016 Oct; 93():123-31. PubMed ID: 27516150
[TBL] [Abstract][Full Text] [Related]
24. AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
Zatorski H; Salaga M; Zielińska M; Majchrzak K; Binienda A; Kordek R; Małecka-Panas E; Fichna J
Molecules; 2021 May; 26(10):. PubMed ID: 34063466
[TBL] [Abstract][Full Text] [Related]
25. AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice.
Fang Q; Li J; Wang Y; Liu X; Shi Y; Chen J; Zhan H; Zeng Y; Wu W
Mediators Inflamm; 2023; 2023():7661791. PubMed ID: 37077671
[TBL] [Abstract][Full Text] [Related]
26. AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments.
Nigro E; Daniele A; Salzillo A; Ragone A; Naviglio S; Sapio L
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070338
[TBL] [Abstract][Full Text] [Related]
27. AdipoRon Attenuates Hypertension-Induced Epithelial-Mesenchymal Transition and Renal Fibrosis via Promoting Epithelial Autophagy.
Li Y; Song B; Ruan C; Xue W; Zhao J
J Cardiovasc Transl Res; 2021 Jun; 14(3):538-545. PubMed ID: 33025271
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
Akimoto M; Maruyama R; Kawabata Y; Tajima Y; Takenaga K
Cell Death Dis; 2018 Jul; 9(8):804. PubMed ID: 30038429
[TBL] [Abstract][Full Text] [Related]
29. AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
Zhang N; Wei WY; Liao HH; Yang Z; Hu C; Wang SS; Deng W; Tang QZ
J Mol Med (Berl); 2018 Dec; 96(12):1345-1357. PubMed ID: 30341569
[TBL] [Abstract][Full Text] [Related]
30. Autophagic and apoptotic proteins in goat corpus luteum and the effect of Adiponectin/AdipoRon on luteal cell autophagy and apoptosis.
Li H; Pei X; Yu H; Wang W; Mao D
Theriogenology; 2024 Jan; 214():245-256. PubMed ID: 37944429
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth.
Nguyen MLT; Pham C; Pham VT; Nham PLT; Ta BT; Le DT; Le QV; Hoang XC; Bozko P; Nguyen LT; Bui KC
Cell Biochem Biophys; 2024 Jan; ():. PubMed ID: 38243102
[TBL] [Abstract][Full Text] [Related]
32. Contribution of transcription factor EB to adipoRon-induced inhibition of arterial smooth muscle cell proliferation and migration.
Wang YT; Chen J; Li X; Umetani M; Chen Y; Li PL; Zhang Y
Am J Physiol Cell Physiol; 2019 Nov; 317(5):C1034-C1047. PubMed ID: 31483704
[TBL] [Abstract][Full Text] [Related]
33. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
34. AdipoRon negatively regulates proliferation and migration of ARPE-19 human retinal pigment epithelial cells.
Mallardo M; Costagliola C; Nigro E; Daniele A
Peptides; 2021 Dec; 146():170676. PubMed ID: 34687793
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
Lindfors S; Polianskyte-Prause Z; Bouslama R; Lehtonen E; Mannerla M; Nisen H; Tienari J; Salmenkari H; Forsgård R; Mirtti T; Lehto M; Groop PH; Lehtonen S
Diabetologia; 2021 Aug; 64(8):1866-1879. PubMed ID: 33987714
[TBL] [Abstract][Full Text] [Related]
37. The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis.
Salmons HI; Gow C; Limberg AK; Bettencourt JW; Carstens MF; Payne AN; Morrey ME; Sanchez-Sotelo J; Berry DJ; Dudakovic A; Abdel MP
Tissue Eng Part C Methods; 2023 Apr; 29(4):154-159. PubMed ID: 36924279
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin Receptor Agonist, AdipoRon, Causes Vasorelaxation Predominantly Via a Direct Smooth Muscle Action.
Hong K; Lee S; Li R; Yang Y; Tanner MA; Wu J; Hill MA
Microcirculation; 2016 Apr; 23(3):207-20. PubMed ID: 26728950
[TBL] [Abstract][Full Text] [Related]
39. Small-molecule agonist AdipoRon alleviates diabetic retinopathy through the AdipoR1/AMPK/EGR4 pathway.
Wang Y; Liu Y; Fang J; Xing X; Wang H; Shi X; Liu X; Niu T; Liu K
J Transl Med; 2024 Jan; 22(1):2. PubMed ID: 38166990
[TBL] [Abstract][Full Text] [Related]
40. AdipoRon prevents myostatin-induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line.
Liu XH; Pan JP; Bauman WA; Cardozo CP
Physiol Rep; 2019 Aug; 7(13):e14152. PubMed ID: 31250564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
